Danaher (DHR)
(Delayed Data from NYSE)
$243.25 USD
-2.14 (-0.87%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $243.25 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$243.25 USD
-2.14 (-0.87%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $243.25 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Zacks News
Can General Electric (GE) Q4 Earnings Beat on Aerospace Boost?
by Zacks Equity Research
Strength in the Aerospace segment and accretive acquisitions are likely to aid General Electric's (GE) fourth-quarter 2023 results.
3M (MMM) Gears Up to Post Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
3M's (MMM) fourth-quarter 2023 results are likely to have gained from strength across its automotive OEM and medical solutions businesses. However, weak commercial solutions and transportation safety markets might have hurt its results.
Why Danaher (DHR) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Danaher (DHR) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Danaher (DHR) reachead $226.75 at the closing of the latest trading day, reflecting a +0.67% change compared to its last close.
Danaher (DHR) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $229.64, moving -0.53% from the previous trading session.
Danaher (DHR) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
Danaher (DHR) concluded the recent trading session at $230.87, signifying a -1.7% move from its prior day's close.
Here's Why Danaher (DHR) Fell More Than Broader Market
by Zacks Equity Research
The latest trading day saw Danaher (DHR) settling at $230.81, representing a -1.7% change from its previous close.
Should You Invest in the Invesco Global Water ETF (PIO)?
by Zacks Equity Research
Sector ETF report for PIO
Danaher (DHR) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Danaher (DHR) concluded the recent trading session at $234.79, signifying a +1.49% move from its prior day's close.
Danaher (DHR) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $232.86, moving +0.63% from the previous trading session.
Reasons to Retain Danaher (DHR) Stock in Your Portfolio Now
by Zacks Equity Research
Strength in the Life Sciences segment and accretive acquisition bode well for Danaher (DHR). The company's measures to reward its shareholders are encouraging.
Danaher (DHR) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $226.45, moving -0.34% from the previous trading session.
Danaher (DHR) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Danaher (DHR) concluded the recent trading session at $221.35, signifying a +1.77% move from its prior day's close.
Danaher (DHR) Acquires Abcam to Boost Life Sciences Segment
by Zacks Equity Research
Danaher (DHR) acquires Abcam for $5.7 billion, thus adding to its Life Sciences portfolio. This move will facilitate the mapping of complex diseases and expedite the drug discovery process.
Danaher (DHR) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
The latest trading day saw Danaher (DHR) settling at $219.44, representing a -1.21% change from its previous close.
Danaher (DHR) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Danaher (DHR) concluded the recent trading session at $222.52, signifying a +1.72% move from its prior day's close.
Danaher (DHR) Up 14.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Invesco Global Water ETF (PIO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PIO
Should You Invest in the Invesco Global Water ETF (PIO)?
by Zacks Equity Research
Sector ETF report for PIO
Tools & Outdoor Weakness Hurt Stanley Black's (SWK) Sales in Q3
by Zacks Equity Research
Weakness in the Tools & Outdoor unit due to lower consumer outdoor and DIY market demand weighs on Stanley Black's (SWK) top line in Q3. However, lower costs drive the bottom line.
Honeywell (HON) Beats on Q3 Earnings & Revenues, Revises View
by Zacks Equity Research
Honeywell's (HON) Q3 results benefit from growth in commercial aviation, defense and space, and process solutions. The company revises its 2023 guidance.
Danaher's (DHR) Q3 Earnings & Revenues Beat, Decline Y/Y
by Zacks Equity Research
While Danaher (DHR) surpasses Q3 earnings and revenue estimates, the company's performance is hurt by a decrease in the sale of COVID-related products and weak demand in the Life Sciences segment.
Here's What Key Metrics Tell Us About Danaher (DHR) Q3 Earnings
by Zacks Equity Research
Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Danaher (DHR) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 10.38% and 3.95%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Danaher (DHR) Stock Moves -0.71%: What You Should Know
by Zacks Equity Research
Danaher (DHR) concluded the recent trading session at $205.83, signifying a -0.71% move from its prior day's close.